Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I clinical trial of JPH203 in patients with solid cancers.

Next Previous
Trial Profile

Phase I clinical trial of JPH203 in patients with solid cancers.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 26 Mar 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nanvuranlat (Primary)
  • Indications Biliary cancer; Colorectal cancer; Pancreatic cancer; Solid tumours
  • Focus Adverse reactions; First in man
  • Sponsors J-Pharma

    • Most Recent Events

    • 20 Mar 2020 Results evaluating JPH203 to determine its safety, maximum tolerated dose (MTD), and recommended phase II dose (RP2D) among Japanese patients with advanced solid tumorspublished in the Investigational New Drugs
    • 05 Jun 2018 Status changed from active, no longer recruiting to completed.
    • 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top